Chopas James George 4

Accession 0001492422-26-000060

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:12 PM ET

Size

4.5 KB

Accession

0001492422-26-000060

Research Summary

AI-generated summary of this filing

Updated Jan 23, 2026

Apellis (APLS) VP James Chopas Sells 2,064 Shares

What Happened James Chopas, VP and Chief Accounting Officer of Apellis Pharmaceuticals (APLS), sold 2,064 shares on January 22, 2026. The shares were disposed at $21.77 per share for a total transaction value of $44,924. The Form 4 lists the transaction type as a sale (S).

Key Details

Transaction date: 2026-01-22; sale price: $21.77; shares sold: 2,064; total proceeds: $44,924.
Transaction reported on SEC Form 4 filed 2026-01-23 (timely filing).
Shares owned after the transaction: not reported in this filing.
Footnote: sale was to cover tax withholding on Restricted Stock Units released January 21, 2026 (F1).
Transaction type: open market or private sale (disposition, code S).

Context The filing shows a sale to satisfy tax withholding tied to RSU vesting— a routine administrative transaction common after equity awards vest. Such sell-to-cover transactions are not necessarily indicative of the insider’s view on the company’s prospects; purchases generally carry more weight as signals of insider confidence.